InvestorsHub Logo
Followers 0
Posts 3521
Boards Moderated 0
Alias Born 03/03/2018

Re: Monksdream post# 146109

Tuesday, 07/31/2018 11:08:13 PM

Tuesday, July 31, 2018 11:08:13 PM

Post# of 203914
Yes..because it is a very young company with a great future yet to be realized..

If you want to compare apples to apples then let's talk about companies that practice real science and don't flood the market with me too products.


OWCP should it realize what it intends to do will be a company more akin to GW one day....

It's very easy to stand and poke fun at the company and it's officers...anyone can do that.

What it takes are balls and fortitude in order to persevere and come out the other side.

How does GW's approach differ in their early days to what OWCP is doing now?

It doesn't. https://www.gwpharm.com/about-us/history-approach

Companies like GW will blaze the trail and ultimately make it a little easier for development stage biotechs like OW...so time frames will be lessened as more acceptance and approval of cannabis based therapeutic agents are approved.

Epidolex is but the first of many to come, and many will come from OWCP imo.


Whoever is careless with the truth in small matters cannot be trusted with important matters.
– Albert Einstein